Hainan Luyan Pharma Co., Ltd. announced that it will received CNY 58.5 million in round of funding on September 11, 2023. The transaction included the participation from new investors Hainan Rangsanchi Science and Trade Co., Ltd., will invest CNY 2.6 million and hold 4% stake, Hainan Guokang Future Healthcare Industry Management Group Co., Ltd., will invest CNY 1.95 million and hold 3% stake and Hainan Qize Yisheng Science and Trade Co., Ltd., will invest CNY 1.95 million and hold 3% stake. The company hold 90% stake.

The company's registered capital is increased from CNY 35 million to CNY 100 million. The company held that the transaction has been approved by the company?s 5th directorate during its 15th meeting, and does not require approval through the company?s shareholders? meeting.